Navigation Links
MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
Date:5/25/2010

MARIETTA, Ga., May 25 /PRNewswire-FirstCall/ -- MiMedx Group, Inc.  (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the Noble Financial Sixth Annual Equity Conference in Hollywood, Florida.  William C. Taylor, President and Chief Operating Officer and Michael J. Senken, Chief Financial Officer of MiMedx, are scheduled to present on Monday, June 7, at 2:30 p.m. Eastern Time at the Hard Rock Hotel in Hollywood, Florida.  

The presentation will be webcast and available for viewing at www.mimedx.com on the "Investors" tab, or through the Noble Financial websites www.ontrack10.com, or www.nobleresearch.com. MiMedx recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will need the SiverLight viewer (a free download from presentation link) to participate. In addition, the webcast, transcript and written materials will be archived on the Company's website for 90 days following the even
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group Announces Temporary Trading Symbol Designation
2. MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors
3. MiMedx Group Announces Post-split Name Change
4. MiMedx Announces Brian J. Splan as President
5. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
6. Encorium Group, Inc. Announces New Business Contract Wins of $6.8 Million, Including Two Pivotal Phase III Studies for a Major Asian Technology Company
7. Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results
8. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
9. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
10. Hanger Orthopedic Group, Inc. Reports an Increase of 30.4% in Earnings Per Share, to $0.30, for the Third Quarter 2009 and Raises Its 2009 Guidance
11. Encorium Group, Inc. Completes $1.6 Million Private Placement of Common Stock and Executes Warrant Exchange Agreement; Ends Discussions to Sell Encorium OY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...
(Date:6/17/2013)... Belvoir, VA (PRWEB) June 17, 2013 ... annual Basic Research Technical Review at the Waterford in ... More than 300 grant awardees will present technical details ... Technical sessions will cover a broad range of counter ... (2) Cognitive, Information and Network Science; (3) Science for ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 With the huge ... launch of the Chief Medical Officer Summit for Emerging Life ... will take place in San Francisco on November 4-5, 2013 ... the first time, West Coast Chief Medical Officers at biotechs ... Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive ...
(Date:6/17/2013)... June 17, 2013 ... announced the addition of the "North ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics- Forecasts ... ,      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3
... , , ... , , , ... analysis.,By comparing the separated bands,of an unknown sample to a ... fragment,can be estimated. The Agilent,2100 bioanalyzer is an instrument,which utilizes ...
... , , ... , , , Whereas in ... molecules, the development of soft ionization methods,such as matrix-assisted laser desorption/ionization ... the analysis of proteins up to 300 kDa using MS has,become ...
... , , , ... , , , , ... studying functional,assays requiring the transfection of small interfering RNA (siRNA),into a cell, ... given cell lines would be of great value.,Three to four siRNA sequences ...
Cached Biology Technology:High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 2High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 3High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 4High resolution DNA analysis with the,DNA 500 and DNA 1000 LabChip kits 5Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 2Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 3Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 4Using the Agilent 2100 bioanalyzer for,quality control of protein samples prior to,MS-analysis 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 2siRNA transfection optimization,with the Agilent 2100 bioanalyzer 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 4siRNA transfection optimization,with the Agilent 2100 bioanalyzer 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 6siRNA transfection optimization,with the Agilent 2100 bioanalyzer 7
(Date:6/17/2013)... Patients in Vietnam and other locations with central nervous ... of a newly discovered virus, according to a study ... open-access journal of the American Society for Microbiology. Researchers ... percent of 642 patients with central nervous system infections ... percent of fecal samples from pigs and poultry, suggesting ...
(Date:6/17/2013)... kids eat their food may turn out to be just ... study out of St. Michael,s Hospital. , The study, ... significant association between poor eating habits in kids ages ... "bad" cholesterol, putting them at risk for cardiovascular disease ... Canadian Medical Association Journal today. , "We ...
(Date:6/17/2013)... of improving original foundations with more modern elements. Using ... Pittsburgh,s Kenneth P. Dietrich School of Arts and Sciences ... drug delivery, gas storage, and gas transport more efficient ... in the latest issue of the Journal of ... The recent work builds upon Pitt Associate Professor of ...
Breaking Biology News(10 mins):New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3Poor eating behaviors may put preschoolers at risk for later health problems 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... circles that rural peasant activities are at odds ... In fact, the opposite is often true, argue ... Perfecto. , Combining case studies with ecological ... farming practices encouraged by grassroots movements such as ...
... mechanism that regulates how many new cells are produced ... in the latest issue of the prestigious scientific journal, ... for things like neurological disorders and anaemia," says Professor ... old cells are continually being replaced by new. If ...
... reaching age 90 with preserved cognition, according to a ... Journal of Geriatric Psychiatry. The study, which was conducted ... to identify genetic links to cognitive longevity. , "Successful ... focused on individuals who had reached at least 90 ...
Cached Biology News:Agriculture and tropical conservation: rethinking old ideas 2Agriculture and tropical conservation: rethinking old ideas 3New stem-cell findings can help the body to cure itself 2New research examines genetics of successful aging 2
ANTI L-DOPA...
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
Recombinant Rat CINC-2 alpha, CF...
sodium channel, nonvoltage-gated 1 alpha,...
Biology Products: